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Review

Zika virus from a neonatologist’s
perspective
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Children’s Hospital at Westchester Medical Center, New York Medical College, Valhalla, NY, USA

Abstract

Zika virus has been known for more than half a century. Its clinical
significance was just recently discovered, after the epidemic of Zika virus
emerged in South and Central America. A task force established in 2015 by
the Brazil Ministry of Health investigated the possible association between
congenital Zika infection and microcephaly in fetuses and newborns. Since
then more and more evidence emerged, supporting this hypothesis. The
objective of this article is to review and summarize the currently available
literature regarding Zika virus from a neonatologist’s standpoint and provide
some guidance to medical providers who may have to care for potentially
exposed pregnant patients and their newborns.
Keywords

Zika virus, pregnancy, transmission, newborn, neonatal outcomes, microcephaly.
Corresponding author
Anna Zylak MD, FAAP, The Regional Neonatal Center, Division of Newborn Medicine, Department of
Pediatrics, Maria Fareri Children’s Hospital at Westchester Medical Center, New York Medical College,
Valhalla, NY, USA; email: anna.zylak@wmchealth.org.

How to cite
Zylak A, Golombek SG. Zika virus from a neonatologist’s perspective. J Pediatr Neonat Individual
Med. 2017;6(1):e060128. doi: 10.7363/060128.

Introduction

Since January 2016 the topic of Zika virus (also known as ZIKV)
infection has been constantly present in the headlines of the largest news
agencies and the most famous medical journals. The suspected association
between Zika virus infection and microcephaly in neonates raised the level
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of anxiety especially in the population of pregnant
women and their medical providers.
Background

Zika virus is a mosquito-borne RNA Flavivirus.
There are 2 known lineages: an African and an
Asian [1]. The virus was discovered by D.W.A.
Dick for the first time in 1947, but not described
in the literature until 1952. It was isolated from a
febrile Rhesus monkey found in the Zika Forest
(hence the name) in Uganda. The first documented
human case was subsequently isolated in Nigeria
in 1954 [2, 3]. Before 2007 only isolated human
disease cases were reported from countries in
Asia and Africa. In 2007 the first documented
outbreak was reported in Yap State, Federated
States of Micronesia, followed by outbreaks in
Southeast Asia, the Western Pacific region and,
most recently, in 2015 in Brazil [4]. On February
1, 2016, WHO has declared the problem of Zika
virus infection a “Public Health Emergency
of International Concern” [5]. The number of
documented cases of Zika virus infection is
constantly at the rise, both worldwide as well as
on US territories [6, 7]. Fig. 1 shows the countries
worldwide with documented active Zika virus
transmissions, as of September 23, 2016, as per
CDC [8].

Transmission occurs most commonly via an
insect vector [1]. There are 2 known vectors: Aedes
aegypti also known as the Yellow fever mosquito;
and Aedes albopictus – the Asian tiger mosquito.
Aedes aegypti is the main vector and can also spread
dengue fever, chikungunya, yellow fever viruses,
and other diseases. It originated from Africa, but
can also be found in most tropical and subtropical
regions of the world (including: South and Central
America, Asia and Polynesia). Aedes albopictus
is more common in Asia, some regions of Europe
and can also be found in North America. New
research has shown that both species are capable
of spreading in the United States further North as
initially anticipated, hence posing a higher risk
of infection transmission [1, 6, 9]. Some authors
also hypothesize that there might be a genetic
basis causing the evolution into new viral types
with the enhanced ability to infect humans [10].
The recent epidemics also revealed other ways of
transmission. It is known that the infection can be
acquired transplacentally and intrapartum [11-13],
via blood transfusions (no documented cases in
the US, but suspected cases in Brazil) [13], as well
as via sexual contact (the virus can be detected in
semen for up to 2 weeks after the acute illness) [14].
Organ transplantation could potentially also pose a
risk for transmission, although there are currently
no known cases worldwide. An interesting issue is

Figure 1. Zika virus (also known as ZIKV) reported active transmission as of September 23, 2016. Data are from the
Centers for Disease Control and Prevention (CDC) [8].
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also the risk of transmission via breastfeeding, the
virus has been detected in breastmilk in 2 cases in
Polynesia [15].
The majority of affected patients is
asymptomatic (80%). The incubation period for
Zika virus disease is still unknown, but is likely
to be a few days to a week. Of those patients
who present with symptoms, the most common
complaints are very nonspecific: low-grade fever,
maculopapular rash, arthralgia, non-purulent
conjunctivitis, myalgia and headache. The illness
is usually mild with symptoms lasting for several
days to a week, rarely causing a severe sickness
requiring medical attention in a hospital setting
or causing death [16]. There are known cases
in the literature of neurological complications
associated with Zika virus infection. Both during
the outbreak in French Polynesia in 2013-2014
and in Brazil in 2015 patients were presenting with
symptoms resembling Guillain-Barré syndrome,
an autoimmune disease characterized by ascending
paralysis [17, 18].
There is currently no curative treatment
available, and the management of Zika positive
patients is based on supportive measures:
hydration, analgesics and antipyretics. The key in
decreasing the numbers of infected patients lies
in prevention, mainly with personal protection,
repellents, barrier contraception [1, 17]. In March
2016 the New York State Government suggested
providing to health care providers “Zika Virus
Protection Kits” containing repellents, condoms
and larvicide tablets to treat standing water [19].
Pathogenesis of microcephaly and other
anomalies due to Zika virus infection and
hypothesis of causation

The clinical significance of a congenital Zika
virus infection was discovered for the first time in
2015 in Brazil. In early 2015, an outbreak of Zika
was identified in northeast Brazil. By September,
reports of a 20-fold increase in the number of infants
born with microcephaly in Zika-affected areas began
to appear. Initially Zika RNA was identified from
the amniotic fluid of 2 women whose fetuses were
diagnosed with microcephaly. Subsequently more
evidence emerged confirming the presence of Zika
virus genetic material in newborn tissues obtained
from neonates with microcephaly shortly after birth
or after termination of pregnancy [17, 20-22].
Viral tropism of Zika to the brain has been
known since 1952. Already back then, research
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was suggesting that the virus can cross the bloodbrain barrier. In mice models the virus infected
both neurons and glia producing a variety of
intracytoplasmic inclusions [2, 3]. Current studies
also report the highest levels of viremia in samples
obtained from the brain tissue of infected fetuses
or neonates. One of the current hypothesis by Tetro
[23] links the pathogenesis of Zika microcephaly
with centrosome abnormalities. Centrosomes are
involved in mitosis, migration, polarity and proper
trafficking of vesicles. Abnormal function of these
organelles can delay mitosis, increase apoptosis,
cause improper neural stem cell orientation and
premature neuronal differentiation, as well as
decrease progenitor cells. By influencing all these
processes, it can lead to reduction of brain formation
subsequently causing a reduced brain size. After
the epidemics in Brazil emerged, several animal
studies were performed on mice to investigate the
mode of transmission on a more cellular level.
The investigators have found that Zika virus most
likely preferentially injures the cortical neuronal
progenitor cells [12]. The death of progenitor
cells initiated by viral induced inflammation could
explain the brain malformations, microcephaly and
cortical thinning. Other authors hypothesize that
there are strong similarities between Zika virus
infection and hypervitaminosis A, a known in utero
teratogen. In the model described by Mawson [24],
an early infection with the virus activates a retinoic
cascade in the liver resulting in an increased
production of retinoic acid. Elevated retinoic acids
levels cause cholestatic liver damage and then
subsequently neuronal apoptosis and necrosis,
leading to growth restriction, microcephaly
and ophthalmologic defects. Rasmussen [25]
published an interesting analysis reviewing the
association between prenatal Zika infection,
microcephaly and other brain abnormalities. By
applying specific criteria for the evaluation of
potential teratogens (also known as Bradford Hill
criteria) on all available evidence they concluded
that there is sufficient evidence supporting the
causal relationship between congenital Zika virus
infection and microcephaly.
Birth defects associated with congenital Zika
virus infection

Besides brain abnormalities (microcephaly,
ventriculomegaly, intracranial calcifications,
neuronal migration disorders, lissencephaly,
pachygyria, corpus callosum dysgenesis) [20-22,
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26-29] and eye abnormalities (microphthalmia,
focal pigment mottling of the retina, chorioretinal
atrophy, optic nerve abnormalities, cataracts, eye
asymmetry, intraocular calcifications, macular
atrophy, lens subluxation) [24, 30], congenital Zika
virus infection can be also associated with congenital
contractures, arthrogryposis and club feet [26].
Additionally, growth restriction was noted in the
affected fetuses and neonates, raising the suspicion
of abnormal placental development or placental
insufficiency caused by Zika virus infection [12,
22]. The relationship between the timing of the
acute maternal infection and the subsequent fetal
abnormalities still remains unknown. Some studies
suggest a 1% chance of developing microcephaly
if the Zika virus infection and subsequent insult
occurred during the first trimester of pregnancy.
This theory corresponds with the known fact, that
the most crucial stages of brain development occur
during that time. Stillbirth has been associated with
acute viral infection late in pregnancy [29].
Diagnostic approach and management in
suspected neonatal cases of Zika virus infection

The CDC guidelines recommend testing of
pregnant women with a possible exposure to Zika
virus. Tests can be performed on both serum and
amniotic fluid – one must remember though the
risks of amniocentesis itself, which can result in
fetal loss in about 0.1% of cases [31]. Additionally,
it is still not known how sensitive and specific the
available testing is and if a positive result is actually
predictive of a subsequent fetal abnormality.
The currently available diagnostic opportunities
include PCR testing for viral RNA, detection of
Zika virus-specific IgM antibodies using ELISA
and plaque reduction neutralization test (PRNT)
for Zika antibodies. Viral RNA can be detected
during the first 7 days of illness, after that the level
of viremia decreases. During that period, molecular
testing is recommended. However, a negative RTPCR performed on days 5-7 of the acute illness
does not exclude Zika virus infection and should
be verified with serological testing. Zika virusspecific IgM antibodies might be detected as early
as on the 4th day of the acute illness and they can
persist 2-12 weeks. However, serum collected
within the first 7 days might not detect specific
Zika virus antibodies. Hence it is recommended
to postpone serologic testing until after 7 days
of illness. Cross reactivity might occur between
Zika virus antibodies and antibodies against
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other Flaviviridae (especially with the increasing
numbers of tourists being vaccinated for Yellow
Fever or Japanese Encephalitis), hence every
positive antibody test should be confirmed with
a plaque-reduction neutralization test (PRNT). A
4-fold or higher increase in specific Zika virus antibody
titers is considered positive [26, 32]. In the case of
a positive Zika test as per CDC serial ultrasound
examinations should be considered to monitor
fetal growth and anatomy every 3-4 weeks. The
pregnant woman should be referred to a Maternal
Fetal Medicine and Infectious Diseases specialist.
After delivery histopathologic examination of the
placenta and umbilical cord is recommended, as
well as testing of frozen placental tissue and cord
tissues for Zika virus RNA and testing of cord
serum for Zika and dengue virus IgM along with
neutralizing antibodies. In the situation of a fetal
loss due to suspected Zika infection, CDC also
highly recommends Zika virus PCR testing and
immunohistochemical staining to be performed
on the fetal tissues, including umbilical cord
and placenta. Zika testing is also recommended
for infants with microcephaly or intracranial
calcifications born to women who traveled to or
resided in areas with Zika virus transmission
while being pregnant as well as for infants born to
mothers with a positive or inconclusive test results
for Zika virus infection. A thorough physical exam
should be performed in all cases of suspected
congenital Zika infection, including an evaluation
for neurologic abnormalities, dysmorphic
features, splenomegaly, hepatomegaly, and rash
or other skin lesions; a hearing evaluation and
an ophthalmologic evaluation. Laboratory testing
for infants includes: serum samples from the
umbilical cord or directly from the baby within
2 days after birth; CSF if clinically warranted;
frozen and fixed placenta tissue. All cases of
confirmed Zika infection should be reported to the
state, territorial, or local health department and
should be monitored for additional guidance as it
is released. Additional hearing screen should be
conducted at age 6 months, due to the possibility of
co-occurrence of CMV infection. Providers should
carefully evaluate occipito-frontal circumference
and developmental milestones at every well child
visit [6, 26, 31, 33]. Although the virus has been
detected in breastmilk in the past in 2 cases in
Polynesia, WHO still recommends breastfeeding,
possibly attributing the infection not directly to
breastfeeding but to close contact between the
mother and the infant [15].
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Conclusions
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14. Oster AM, Russell K, Stryker JE, Friedman A, Kachur RE,
Petersen EE, Jamieson DJ, Cohn AC, Brooks JT. Update: Interim

What are our hopes for the future? Some
experts are hoping that the Zika virus will behave
similarly to rubella: most of the population gets it
and subsequently most of the population becomes
immune. Nevertheless, several research labs are
currently working on developing a vaccine, which
should soon enter the first phase of clinical trials
[34, 35].
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